Literature DB >> 11090191

Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells.

H Mikkola1, N B Woods, M Sjögren, H Helgadottir, I Hamaguchi, S E Jacobsen, D Trono, S Karlsson.   

Abstract

Human immunodeficiency virus type 1-based lentivirus vectors containing the green fluorescent protein (GFP) gene were used to transduce murine Lin(-) c-kit(+) Sca1(+) primitive hematopoietic progenitor cells. Following transduction, the cells were plated into hematopoietic progenitor cell assays in methylcellulose and the colonies were scored for GFP positivity. After incubation for 20 h, lentivirus vectors transduced 27.3% +/- 6.7% of the colonies derived from unstimulated target cells, but transduction was more efficient when the cells were supported with stem cell factor (SCF) alone (42. 0% +/- 5.5%) or SCF, interleukin-3 (IL-3), and IL-6 (53.3 +/- 1.8%) during transduction. The, vesicular stomatitis virus glycoprotein-pseudotyped MGIN oncoretrovirus control vector required IL-3, IL-6, and SCF for significant transduction (39.3 +/- 9.4%). Interestingly, only a portion of the progeny cells within the lentivirus-transduced methylcellulose colonies expressed GFP, in contrast to the homogeneous expression in oncoretrovirus-transduced colonies. Secondary plating of the primary GFP(+) lentivirus vector-transduced colonies revealed vector PCR(+) GFP(+) (42%), vector PCR(-) GFP(-) (46%), and vector PCR(+) GFP(-) (13%) secondary colonies, indicating true genetic mosaicism with respect to the viral genome in the progeny cells. The degree of vector mosaicism in individual colonies could be reduced by extending the culture time after transduction and before plating into the clonal progenitor cell assay, indicating a delay in the lentiviral integration process. Furthermore, supplementation with exogenous deoxynucleoside triphosphates during transduction decreased mosaicism within the colonies. Although cytokine stimulation during transduction correlates with higher transduction efficiency, rapid cell division after transduction may result in loss of the viral genome in the progeny cells. Therefore, optimal transduction may require activation without promoting intense cell proliferation prior to vector integration.

Entities:  

Mesh:

Year:  2000        PMID: 11090191      PMCID: PMC112474          DOI: 10.1128/jvi.74.24.11911-11918.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector.

Authors:  J J Han; A N Mhatre; M Wareing; R Pettis; W Q Gao; R N Zufferey; D Trono; A K Lalwani
Journal:  Hum Gene Ther       Date:  1999-07-20       Impact factor: 5.695

2.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

3.  Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors.

Authors:  J Douglas; P Kelly; J T Evans; J V Garcia
Journal:  Hum Gene Ther       Date:  1999-04-10       Impact factor: 5.695

4.  Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease.

Authors:  N Déglon; J L Tseng; J C Bensadoun; A D Zurn; Y Arsenijevic; L Pereira de Almeida; R Zufferey; D Trono; P Aebischer
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

5.  Efficient lentiviral transduction of liver requires cell cycling in vivo.

Authors:  F Park; K Ohashi; W Chiu; L Naldini; M A Kay
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

6.  Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors.

Authors:  J T Evans; P F Kelly; E O'Neill; J V Garcia
Journal:  Hum Gene Ther       Date:  1999-06-10       Impact factor: 5.695

7.  Infection of intact human islets by a lentiviral vector.

Authors:  N Giannoukakis; Z Mi; A Gambotto; A Eramo; C Ricordi; M Trucco; P Robbins
Journal:  Gene Ther       Date:  1999-09       Impact factor: 5.250

8.  Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells.

Authors:  A A Bukovsky; J P Song; L Naldini
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes.

Authors:  Y D Korin; J A Zack
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

10.  Efficient and sustained transgene expression in human corneal cells mediated by a lentiviral vector.

Authors:  X Wang; B Appukuttan; S Ott; R Patel; J Irvine; J Song; J H Park; R Smith; J T Stout
Journal:  Gene Ther       Date:  2000-02       Impact factor: 5.250

View more
  7 in total

1.  Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo.

Authors:  Yung-Wei Pan; Jarrad M Scarlett; Tammy T Luoh; Peter Kurre
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

2.  Imaging stem cell-derived persistent foci after in vivo selection of lentiviral MGMT-P140K transduced murine bone marrow cells.

Authors:  Yuan Lin; Perrin Cheung; Justin C Roth; David L Wilson; Stanton L Gerson
Journal:  Mol Ther       Date:  2011-02-08       Impact factor: 11.454

Review 3.  Gene-circuit therapy on the horizon: synthetic biology tools for engineered therapeutics.

Authors:  Rafał Krzysztoń; Yiming Wan; Julia Petreczky; Gábor Balázsi
Journal:  Acta Biochim Pol       Date:  2021-08-30       Impact factor: 2.149

4.  Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.

Authors:  E J R Nelson; L M Tuschong; M J Hunter; T R Bauer; T H Burkholder; D D Hickstein
Journal:  Gene Ther       Date:  2010-02-18       Impact factor: 5.250

5.  The CpG-sites of the CBX3 ubiquitous chromatin opening element are critical structural determinants for the anti-silencing function.

Authors:  Jessica Kunkiel; Natascha Gödecke; Mania Ackermann; Dirk Hoffmann; Axel Schambach; Nico Lachmann; Dagmar Wirth; Thomas Moritz
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

6.  Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency.

Authors:  H H Abdul-Razak; C J Rocca; S J Howe; M E Alonso-Ferrero; J Wang; R Gabriel; C C Bartholomae; C H V Gan; M I Garín; A Roberts; M P Blundell; V Prakash; F J Molina-Estevez; J Pantoglou; G Guenechea; M C Holmes; P D Gregory; C Kinnon; C von Kalle; M Schmidt; J A Bueren; A J Thrasher; R J Yáñez-Muñoz
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

7.  Reconstitution of the myeloid and lymphoid compartments after the transplantation of autologous and genetically modified CD34+ bone marrow cells, following gamma irradiation in cynomolgus macaques.

Authors:  Sonia Derdouch; Wilfried Gay; Didier Nègre; Stéphane Prost; Mikael Le Dantec; Benoît Delache; Gwenaelle Auregan; Thibault Andrieu; Jean-Jacques Leplat; François-Loïc Cosset; Roger Le Grand
Journal:  Retrovirology       Date:  2008-06-19       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.